Navigation Links
Alexza to Report 2014 Second Quarter Financial Results on Thursday, August 7, 2014
Date:7/17/2014

; is Alexza's first commercial product and it has been approved for sale by the U.S. Food and Drug Administration and the European Commission. Teva Pharmaceuticals USA, Inc. is Alexza's commercial partner for ADASUVE in the U.S. Grupo Ferrer Internacional S.A. is Alexza's commercial partner for ADASUVE in Europe, Latin America and the Commonwealth of Independent States countries.

ADASUVE® and Staccato® are registered trademarks of Alexza Pharmaceuticals, Inc.

Safe Harbor Statement
The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the ability of Alexza and its partners, Teva and Ferrer, to effectively and profitably commercialize ADASUVE, estimated product revenues and royalties associated with the sale of ADASUVE, the adequacy of the Company's capital to support the Company's operations, and the Company's ability to raise additional funds and the potential terms of such potential financings. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and the Company's other Periodic and Current Reports filed with the Securities and E
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
2. Alexza Reports 2013 Third Quarter Financial Results
3. Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
4. Edison expands North American healthcare sector coverage with initiation of coverage on Alexza Pharmaceuticals
5. Alexza Reports Preliminary 2013 Second Quarter Financial Results
6. Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference
7. Alexza Reports 2013 First Quarter Financial Results
8. Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
9. Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013
10. Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
11. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... -- Obsidian HDS, the developer of PharmaShine ( www.pharmashine.com ... of data on pharmaceutical and device industry payments to ... 2014 Open Payments General and Research data released by ... data disclosed on Open Payments for 2014 includes information ... $6.49 billion and is the largest public disclosure of ...
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ESSA Pharma ... its common shares have been approved for listing and trading ... ESSA will begin trading on NASDAQ on July ... TSX Venture Exchange under the symbol "EPI". As ... the NASDAQ, each of the Company,s outstanding special warrants issued ...
(Date:7/2/2015)... OXFORD, England , July 2, 2015 ... commonly known as ,Friendly Aedes aegypti , ... of Juazeiro, Brazil by 95%, ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The ... of a trial of Oxitec,s genetically engineered mosquitoes. The ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why certain ... to read the complete story , just posted on the Surviving Mesothelioma website. ... New York University exposed mice with a mutation on the tumor suppressor gene called ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national president recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar Association ... 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law ... of investigating these types of cases. , Each year, New York State residents ...
(Date:7/3/2015)... Louis, MO (PRWEB) , ... July 03, 2015 , ... ... responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... in the United States, named Mariah N. Manzanares, MD as the new Medical Director ... the new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3
... Like the bleeps of an alarm clock, TeleCare, a home ... time to take your vitals." Researchers from Case Western ... TeleCare is in keeping individuals with complex health issues healthy ... on Aging and Health awarded a one-year pilot grant to ...
... ... KRON TV 4 recently awarded Dr. Michael Macdonald of the Aesthetic ... the Bay awards. Dr. Macdonald is one of the few cosmetic surgeons ... Facial Plastic and Reconstructive Surgery and Head and Neck Surgery. ,With over ...
... ... of successes in its Wide Format Digital Printing and ID Badge divisions. , ... Memphis, TN (PRWEB) April ... despite the tough economy. The company’s two distinct product divisions, Wide Format Digital Printing ...
... ... and mere months left to meet the global 2010 targets in the fight against the ... health specialists from the U.S. and Zambia to press American congressional leaders to keep ... ...
... ... Recent botanical research shows rash-inducing plants are growing faster and producing more ... carbon-dioxide levels appear to create ideal conditions for these poisonous plants, producing ... toxins are produced by plants, the topical reactions become worse and affect ...
... ... heart disease or associated risk factors, today introduced ,How Your Brain Can Save Your ... which research has shown to be critical for making permanent lifestyle changes that increase ... ...
Cached Medicine News:Health News:CWRU study examines effectiveness of telemonitoring vital signs 2Health News:Dr. Michael Macdonald Named Best Plastic Surgeon in San Francisco Bay Area 2Health News:Dr. Michael Macdonald Named Best Plastic Surgeon in San Francisco Bay Area 3Health News:LSI Earns 3M Warranty Certification; Gains Federal ID Badge Contracts 2Health News:LSI Earns 3M Warranty Certification; Gains Federal ID Badge Contracts 3Health News:World Vision Malaria Experts Available for Comment as World Malaria Day Approaches April 25 2Health News:World Vision Malaria Experts Available for Comment as World Malaria Day Approaches April 25 3Health News:Global Warming Increases The Potency Of Poison Ivy and Natural Antidotes 2Health News:Global Warming Increases The Potency Of Poison Ivy and Natural Antidotes 3Health News:Global Warming Increases The Potency Of Poison Ivy and Natural Antidotes 4Health News:HeartCoaches Introduces Brain-Based Strategies for a Healthy Heart 2Health News:HeartCoaches Introduces Brain-Based Strategies for a Healthy Heart 3
3 mm forked angled blades. Blade spread 7 mm. Flat serrated handle with polished finish. Overall length: 4.8 inches....
5 mm curved hook with markings at 14 mm and 20 mm from tip. Flat serrated handle with polished finish. Overall length: 4.7 inches....
Small bulbous tip with flat sides. Flat serrated handle with polished finish. Overall length: 5.1 inches....
This teardrop-shaped tip with multi-angled shaft is ideal for the "Miracle Multiple-Cut" technique and is used for dividing and manipulating nucleus material from all directions in the capsule. Round...
Medicine Products: